Lessons from IgA Nephropathy Models
International Journal of Molecular Sciences · 25.10.2024 · 25 (21) · 11484
DOI: 10.3390/ijms252111484 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2024. Verfasst von Toshiki Kano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Disease Models, Animal, Immunoglobulin A. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.
Abstract (Originalsprache)
IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis worldwide; however, the underlying mechanisms of this disease are not fully understood. This review explores several animal models that provide insights into IgAN pathogenesis, emphasizing the roles of aberrant IgA1 glycosylation and immune complex formation. It discusses spontaneous, immunization, and transgenic models illustrating unique aspects of IgAN development and progression. The animal models, represented by the grouped ddY (gddY) mouse, have provided guidance concerning the multi-hit pathogenesis of IgAN. In this paradigm, genetic and environmental factors, including the dysregulation of the mucosal immune system, lead to increased levels of aberrantly glycosylated IgA, nephritogenic immune complex formation, and subsequent glomerular deposition, followed by mesangial cell activation and injury. Additionally, this review considers the implications of clinical trials targeting molecular pathways influenced by IgAN (e.g., a proliferation-inducing ligand [APRIL]). Collectively, these animal models have expanded the understanding of IgAN pathogenesis while facilitating the development of therapeutic strategies that are currently under clinical investigation. Animal-model-based studies have the potential to facilitate the development of targeted therapies with reduced side effects for IgAN patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.
- Department of Nephrology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.
ORCID-Profile: Hitoshi Suzuki, Yusuke Fukao, Maiko Nakayama
Förderung
- Japan Society for the Promotion of Science
- JSPS KAKENHI
Zitieren
APA
Kano, T., Suzuki, H., Makita, Y., Nihei, Y., Fukao, Y., Nakayama, M., Lee, M., Aoki, R., Yamada, K., Muto, M., & Suzuki, Y. (2024). Lessons from IgA Nephropathy Models. International Journal of Molecular Sciences, 25(21), 11484. https://doi.org/10.3390/ijms252111484
Vancouver
Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, et al. Lessons from IgA Nephropathy Models. International Journal of Molecular Sciences. 2024;25(21):11484. doi:10.3390/ijms252111484
BibTeX
@article{Kano2024,
author = {Kano, Toshiki and Suzuki, Hitoshi and Makita, Yuko and Nihei, Yoshihito and Fukao, Yusuke and Nakayama, Maiko and Lee, Mingfeng and Aoki, Ryosuke and Yamada, Koshi and Muto, Masahiro and Suzuki, Yusuke},
title = {Lessons from IgA Nephropathy Models},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {21},
pages = {11484},
doi = {10.3390/ijms252111484}
}
EUVIMED